Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim Kinnaird

Showing results (131-140 of 139) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 139 results.
International Journal of Cardiology|September 20, 2018
Incidence and predictors of bleeding in ACS patients treated with PCI and prasugrel or ticagrelor: An analysis from the RENAMI registryFabrizio D'Ascenzo, Alberto Grosso, Emad Abu-Assi, et al.
The New England Journal of Medicine|November 28, 2023
A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable AnginaChristopher A Rajkumar, Michael J Foley, Fiyyaz Ahmed-Jushuf, et al.
Cardiovascular Drugs and Therapy|July 5, 2021
Ticagrelor or Clopidogrel After an Acute Coronary Syndrome in the Elderly: A Propensity Score Matching Analysis from 16,653 Patients Treated with PCI Included in Two Large Multinational RegistriesMatteo Bianco, Alessandro Careggio, Carlo Alberto Biolè, et al.
International Journal of Cardiology|December 2, 2019
Comparative external validation of the PRECISE-DAPT and PARIS risk scores in 4424 acute coronary syndrome patients treated with prasugrel or ticagrelorMatteo Bianco, Fabrizio D'ascenzo, Sergio Raposeiras Roubin, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|October 6, 2019
Efficacy and Safety of Clopidogrel, Prasugrel and Ticagrelor in ACS Patients Treated with PCI: A Propensity Score Analysis of the RENAMI and BleeMACS RegistriesMattia Peyracchia, Andrea Saglietto, Carloalberto Biolè, et al.
American Heart Journal|December 7, 2019
Average daily ischemic versus bleeding risk in patients with ACS undergoing PCI: Insights from the BleeMACS and RENAMI registriesFabrizio D'Ascenzo, Carloalberto Biolè, Sergio Raposeiras-Roubin, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|September 13, 2019
P2Y12 inhibitors in acute coronary syndrome patients with renal dysfunction: an analysis from the RENAMI and BleeMACS projectsOvidio De Filippo, Fabrizio D'Ascenzo, Sergio Raposeiras-Roubin, et al.
Atherosclerosis|August 14, 2021
Impact of SARS-CoV-2 positivity on clinical outcome among STEMI patients undergoing mechanical reperfusion: Insights from the ISACS STEMI COVID 19 registryGiuseppe De Luca, Niels Debel, Miha Cercek, et al.
Journal of the American College of Cardiology|November 13, 2020
Impact of COVID-19 Pandemic on Mechanical Reperfusion for Patients With STEMIGiuseppe De Luca, Monica Verdoia, Miha Cercek, et al.
Pageof 14

Showing results (131-140 of 139) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 139 results.
International Journal of Cardiology|September 20, 2018
Incidence and predictors of bleeding in ACS patients treated with PCI and prasugrel or ticagrelor: An analysis from the RENAMI registryFabrizio D'Ascenzo, Alberto Grosso, Emad Abu-Assi, et al.
The New England Journal of Medicine|November 28, 2023
A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable AnginaChristopher A Rajkumar, Michael J Foley, Fiyyaz Ahmed-Jushuf, et al.
Cardiovascular Drugs and Therapy|July 5, 2021
Ticagrelor or Clopidogrel After an Acute Coronary Syndrome in the Elderly: A Propensity Score Matching Analysis from 16,653 Patients Treated with PCI Included in Two Large Multinational RegistriesMatteo Bianco, Alessandro Careggio, Carlo Alberto Biolè, et al.
International Journal of Cardiology|December 2, 2019
Comparative external validation of the PRECISE-DAPT and PARIS risk scores in 4424 acute coronary syndrome patients treated with prasugrel or ticagrelorMatteo Bianco, Fabrizio D'ascenzo, Sergio Raposeiras Roubin, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|October 6, 2019
Efficacy and Safety of Clopidogrel, Prasugrel and Ticagrelor in ACS Patients Treated with PCI: A Propensity Score Analysis of the RENAMI and BleeMACS RegistriesMattia Peyracchia, Andrea Saglietto, Carloalberto Biolè, et al.
American Heart Journal|December 7, 2019
Average daily ischemic versus bleeding risk in patients with ACS undergoing PCI: Insights from the BleeMACS and RENAMI registriesFabrizio D'Ascenzo, Carloalberto Biolè, Sergio Raposeiras-Roubin, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|September 13, 2019
P2Y12 inhibitors in acute coronary syndrome patients with renal dysfunction: an analysis from the RENAMI and BleeMACS projectsOvidio De Filippo, Fabrizio D'Ascenzo, Sergio Raposeiras-Roubin, et al.
Atherosclerosis|August 14, 2021
Impact of SARS-CoV-2 positivity on clinical outcome among STEMI patients undergoing mechanical reperfusion: Insights from the ISACS STEMI COVID 19 registryGiuseppe De Luca, Niels Debel, Miha Cercek, et al.
Journal of the American College of Cardiology|November 13, 2020
Impact of COVID-19 Pandemic on Mechanical Reperfusion for Patients With STEMIGiuseppe De Luca, Monica Verdoia, Miha Cercek, et al.
Pageof 14